Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase

…, S Bongarzone, R Brun, RL Krauth-Siegel…

Index: Cavalli, Andrea; Lizzi, Federica; Bongarzone, Salvatore; Brun, Reto; Luise Krauth-Siegel; Bolognesi, Maria Laura Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 11 p. 3031 - 3035

Full Text: HTML

Citation Number: 30

Abstract

Novel quinazoline-type compounds were designed as inhibitors of the parasite specific enzyme trypanothione reductase (TR), and their biological activities were evaluated. Some of our compounds inhibited TR, showed selectivity for TR over human glutathione reductase, and inhibited parasite growth in vitro. We propose that the quinazoline framework is a privileged structure that can be purposely modified to design novel TR inhibitors. ...

Related Articles:

Pharmacological exploitation of the α1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt …

[Journal of medicinal chemistry, , vol. 47, # 18 p. 4453 - 4462]

Parallel synthesis of N-arylpiperazines using polymer-assisted reactions

[Tetrahedron Letters, , vol. 47, # 15 p. 2549 - 2552]

More Articles...